EPA Revives 2035 Animal Testing Phase-Out While PFAS Drinking Water Limits Hold in Court
Photo by Josian Marsura on Unsplash
EPA Revives 2035 Animal Testing Phase-Out While PFAS Drinking Water Limits Hold in Court
Two Major EPA Developments
Two significant EPA policy moves are playing out simultaneously. First, the agency is reinstating a 2035 deadline to reduce its reliance on animal testing for chemical evaluations — a goal originally set in 2019 but abandoned by the Biden administration in 2024 over feasibility concerns. Second, a federal appeals court has rejected the EPA's attempt to rescind drinking water limits for four PFAS chemicals, keeping the full 2024 rule in effect.
Both developments affect how chemicals are tested, regulated, and ultimately how they reach the market.
Why These Changes Matter
The animal testing phase-out signals a shift in how chemicals will be evaluated for safety. Rather than mandating alternative methods, the EPA will “encourage” researchers to use non-animal approaches including in vitro tests, computational models, and in chemico assays. The FDA is moving in the same direction, indicating plans to phase out animal models over 3 to 5 years and potentially expedite reviews of studies using alternative methods.
For chemical suppliers and buyers, this could eventually speed up the approval pipeline for new chemicals and formulations. It could also affect how existing chemicals are reassessed under programs like TSCA.
The PFAS ruling has more immediate practical impact. Water systems nationwide must complete initial PFAS monitoring by 2027 under the 2024 rule, and the court's decision to keep the full rule in place — despite the administration's preference to defend limits only on PFOA and PFOS — means compliance obligations remain broad.
Key Details on Both Fronts
Animal Testing Phase-Out
- EPA reinstating 2035 target to reduce (not eliminate) animal testing for chemical evaluations
- The agency will encourage, not mandate, alternative testing methods
- FDA plans to phase out animal models over 3-5 years
- NIH is establishing a new Office of Research Innovation, Validation, and Application to fund non-animal testing research
- A minimal amount of animal testing will still be required for some regulatory decisions
PFAS Drinking Water Limits
- Federal court rejected EPA's motion to rescind limits on four PFAS compounds
- The administration is defending limits only on PFOA and PFOS, while seeking to roll back limits on three other compounds and related mixtures
- The full 2024 rule remains in effect pending further court review
- Water systems must complete initial monitoring by 2027
- Merit-based decisions on the rule are expected in fall 2026
What to Watch Next
- Chemical suppliers should monitor whether alternative testing methods accelerate or complicate product registrations under TSCA
- Water treatment operators should continue PFAS monitoring preparations regardless of the administration's legal position — the rule is enforceable now
- Industrial buyers of PFAS-containing products should track the fall 2026 court decisions that will determine the final scope of drinking water limits
- EHS professionals should stay current on how testing methodology changes could affect SDS and exposure limit data for chemicals they handle
Alliance's Take
Both of these EPA developments affect the chemical supply chain. Changes to testing methodology could eventually alter how chemicals are evaluated and approved, while PFAS regulations directly impact water treatment operations and industrial processes. Alliance Chemical stays current on regulatory changes so our customers have the documentation and product information they need for compliance.
For water treatment facilities preparing for PFAS monitoring deadlines, Alliance supplies a full range of water treatment chemicals with complete SDS and COA documentation. Our laboratory chemicals support analytical testing programs, including PFAS sampling and analysis workflows.
Have questions about how regulatory changes affect your chemical purchasing or documentation needs? Contact our team at sales@alliancechemical.com for product specifications, safety data, and supply planning support.
Related Products
Frequently Asked Questions
What is the EPA's timeline for phasing out animal testing in chemical evaluations?
The EPA has reinstated a 2035 deadline to reduce reliance on animal testing for chemical evaluations. While not a total elimination, the agency encourages researchers to use alternative methods like in vitro tests and computational models. This shift aims to modernize safety assessments under programs like TSCA while potentially accelerating the approval pipeline for new formulations.
How does the recent court ruling affect PFAS drinking water regulations?
A federal appeals court recently rejected an EPA attempt to rescind limits for four PFAS chemicals, keeping the full 2024 rule in effect. Consequently, water systems nationwide must still complete initial PFAS monitoring by 2027. Industrial buyers and water treatment operators should prepare for compliance as the rule remains enforceable pending further court reviews in late 2026.
What alternative methods is the EPA encouraging instead of animal testing?
The EPA is promoting non-animal approaches including in vitro tests, computational models, and in chemico assays. Additionally, the NIH is establishing a new Office of Research Innovation, Validation, and Application to fund research into these alternative methods. These changes reflect a broader regulatory movement, with the FDA also planning to phase out animal models over three to five years.
What are the upcoming deadlines for PFAS monitoring and compliance?
Under the current 2024 rule, water systems are required to complete initial PFAS monitoring by 2027. Although the administration sought to roll back limits on certain compounds, the court's decision to maintain the full rule means compliance obligations remain broad. Merit-based decisions regarding the final scope of these drinking water limits are expected to arrive in fall 2026.